Cobalt chloride-induced downregulation of puromycin-sensitive Aminopeptidase suppresses the migration and invasion of PC-3 cells

Journal of Microbiology and Biotechnology

Volumn 19, Issue 5, 2009, Pages 530-536

  Lee, Suk Hee ^a   Kim, Hwan Gyu ^a  

^a Chonbuk National University   (South Korea)

Author keywords

Angiogenesis; Cobalt chloride; Migration; MMPs; PSA

Indexed keywords

AMINOPEPTIDASE; COBALT CHLORIDE; GELATINASE B; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE; PUROMYCIN;

ANGIOGENESIS; ARTICLE; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; PROTEIN SECRETION;

AMINOPEPTIDASES; ANTIMUTAGENIC AGENTS; CELL HYPOXIA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; COBALT; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MATRIX METALLOPROTEINASE 9; NEOVASCULARIZATION, PATHOLOGIC;

EID: 67649432959     PISSN: 10177825     EISSN: 17388872     Source Type: Journal    
DOI: 10.4014/jmb.0807.438     Document Type: Article

References (28)

1. Akada, T., T. Yamazaki, H. Miyashita, O. Niizeki, M. Abe, A. Sato, S. Satomi, and Y. Sato. 2002. Puromycin insensitive leucyl-specific aminopeptidase (PILSAP) is involved in the activation of endothelial integrins. J. Cell Physiol. 193: 253-262.
2. Bergers, G. and L. E. Benjamin. 2003. Tumorigenesis and the angiogenic switch. Nat. Rev. Cancer 3: 401-410.
3. Bhagwat, S. V., J. Lahdenranta, R. Giordano, W. Arap, R. Pasqualini, and L. H. Shapiro. 2001. CD13/APN is activated by angiogenic signals and is essential for capillary tube formation. Blood 97: 652-659.
4. Brahimi-Horn, C., E. Berra, and J. Pouyssegur. 2001. Hypoxia: The tumor's gateway to progression along the angiogenic pathway. Trends Cell Biol. 11: S32-S36.
5. Bunn, H. F. and R. O. Poyton. 1996. Oxygen sensing and molecular adaptation to hypoxia. Physiol. Rev. 76: 839-885.
6. Caudroy, S., M. Polette, B. Nawrocki-Raby, J. Cao, B. P. Toole, S. Zucker, and P. Birembaut. 2002. EMMPRIN-mediated MMP regulation in tumor and endothelial cells. Clin. Exp. Metastasis 19: 697-702.
7. Constam, D. B., A. R. Tobler, A. Rensing-Ehl, I. Kemler, L. B. Hersh, and A. Fontana. 1995. Puromycin-sensitive aminopeptidase. Sequence analysis, expression, and functional characterization. J. Biol. Chem. 270: 26931-26939.
8. Du, R., K. V. Lu, C. Petritsch, P. Liu, R. Ganss, E. Passegue, et al. 2008. HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13: 206-220.
9. Egeblad, E. and Z. Werb. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2: 161-174.
10. Folkman, J. and M. Klagsbrun. 1987. Angiogenic factors. Science 235: 442-447.
11. Folkman, J. and Y. Shing. 1992. Angiogenesis. J. Biol. Chem. 267: 10931-10934.
12. Genbacev, O., Y. Zhou, J. W. Ludlow, and S. J. Fisher. 1997. Regulation of human placental development by oxygen tension. Science 277: 1669-1672.
13. Griffith, E. C., Z. Su, B. E. Turk, S. Chen, Y. H. Chang, and J. O. Liu. 1997. Methionine aminopeptidase (type 2) is the common target for angiogenesis inhibitors AGM-1470 and ovalicin. Chem. Biol. 4: 461-471.
14. Gupta, G. P. and J. Massague. 2006. Cancer metastasis: Building a framework. Cell 127: 679-695.
15. Hersh, L. B., T. E. Smith, and J. F. McKelvy. 1980. Cleavage of endorphins to des-Tyr endorphins by homogeneous bovine brain aminopeptidase. Nature 286: 160-162.
16. Kakuta, H., A. Tanatani, K. Nagasawa, and Y. Hashimoto. 2003. Specific nonpeptide inhibitors of puromycin-sensitive aminopeptidase with a 2, 4 (1H, 3H)-quinazolinedione skeleton. Chem. Pharm. Bull. 51: 1273-1282.
17. Klagsbrun, M. and P. A. D'Amore. 1991. Regulators of angiogenesis. Annu. Rev. Physiol. 53: 217-239.
18. Komoda, M., H. Kakuta, H. Takahashi, Y. Fujimoto, S. Kadoya, F. Kato, and Y. Hashimoto. 2001. Specific inhibitor of puromycin-sensitive aminopeptidase with a homophthalimide skeleton: Identification of the target molecule and a structure-activity relationship study. Bioorg. Med. Chem. 9: 121-131.
19. Lockhart, D. J. and E. A. Winzeler. 2000. Genomics, gene expression and DNA arrays. Nature 405: 827-836.
20. Marchio, S., J. Lahdenranta, R. O. Schlingemann, D. Valdembri, P. Wesseling, M. A. Arap, et al. 2004. Aminopeptidase A is a functional target in angiogenic blood vessels. Cancer Cell 5: 151-162.
21. Miyashita, H., T. Yamazaki, T. Akada, O. Niizeki, M. Ogawa, S. Nishikawa, and Y. Sato. 2002. A mouse orthologue of puromycin-insensitive leucyl-specific aminopeptidase is expressed in endothelial cells and plays an important role in angiogenesis. Blood 99: 3241-3249.
22. Saric, T., C. I. Graef, and A. L. Goldberg. 2004. Pathway for degradation of peptides generated by proteasomes: A key role for thimet oligopeptidase and other metallopeptidases. J. Biol. Chem. 279: 46723-46732.
23. Sato, Y. 2004. Role of aminopeptidase in angiogenesis. Biol. Pharm. Bull. 27: 772-776.
24. Schugart, R. C., A. Friedman, R. Zhao, and C. K. Sen. 2008. Wound angiogenesis as a function of tissue oxygen tension: A mathematical model. Proc. Natl. Acad. Sci. U.S.A. 105: 2628-2633.
25. Stoltze, L., M. Schirle, G. Schwarz, C. Schroter, M. W. Thompson, L. B. Hersh, et al. 2000. Two new proteases in the MHC class I processing pathway. Nat. Immunol. 1: 413-418.
26. Su, Y., J. Zhang, and R. Xiu. 2006. Down-regulation of hepatocyte growth factor mRNA in rat cardiac myocytes under hypoxia mimicked by cobalt chloride. Clin. Hemorheol. Microcirc. 34: 201-206.
27. Yamazaki, T., T. Akada, O. Niizeki, T. Suzuki, H. Miyashita, and Y. Sato. 2004. Puromycin-insensitive leucyl-specific aminopeptidase (PILSAP) binds and catalyzes PDK1, allowing VEGF-stimulated activation of S6K for endothelial cell proliferation and angiogenesis. Blood 104: 2345-2352.
28. Zhao, P., X. G. Li, M. Yang, Q. Shao, D. Wang, S. Liu, et al. 2008. Hypoxia suppresses the production of MMP-9 by human monocyte-derived dendritic cells and requires activation of adenosine receptor A2b via cAMP/PKA signaling pathway. Mol. Immunol. 45: 2187-2195.